Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus

Autoimmunity

Volumn 38, Issue 6, 2005, Pages 439-444

  San Pedro, J I ^a   Bilbao, J R ^a,b   Perez De Nanclares, G ^a   Vitoria, J C ^a,b   Martul, P ^a,b   Castano L ^a,b  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Association; Autoimmune diseases; Celiac disease; Genetics; Type 1 diabetes; Vitamin D receptor

Indexed keywords

RESTRICTION ENDONUCLEASE; VITAMIN D RECEPTOR;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE FREQUENCY; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PROGENY; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SPAIN; STATISTICAL SIGNIFICANCE;

CELIAC DISEASE; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GENETIC HETEROGENEITY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; VARIATION (GENETICS);

EID: 27944485800     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930500288455     Document Type: Article

References (45)

1. Sollid LM. The molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
2. Trier JS. Diagnosis of celiac sprue. Gastroenterol 1998;115:211-216.
3. Feighery C. Coeliac disease. BMJ 1999;319:236-239.
4. Marsh MN. Mucosal pathology in gluten sensitivity. In: Marsh MN, editor. Coeliac disease. Oxford: Blackwell Scientific Publications; 1992. p 136-191.
5. Polanco I, Biemond I, van Leeuwen A. Gluten sensitive enteropathy in Spain: Genetic and environmental factors. In: McConnell RB, editor. The genetics of coeliac disease. Lancaster: MTP Press; 1981. p 211-234.
6. Vitoria JC, Arrieta A, Astigarraga I, Garcia-Masdevall MD, Rodriguez-Soriano J. Serological markers as screening test in family menbers of patients with coeliac disease. J Pediatr Gastroenterol Nutr 1994;19:304-309.
7. Vitoria JC, Castano L, Rica I, Bilbao JR, Arrieta A, Garcia-Masdevall MD. Association of insulin-dependent diabetes mellitus and celiac disease: A study based on serologic markers. J Pediatr Gastroenterol Nutr 1998;27:47-52.
8. Bilbao JR, Martín-Pagola A, Pérez de Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L. HLA-DRB1 and MICA in autoimmunity: Common associated alleles in autoimmune, disorders. Ann NY Acad Sci 2003;1003:314-318.
9. Holopainen P, Arvas M, Sistonen P, Mustalahti K, Collin P, Maki M, Partanen J. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study. Tissue Antigens 1999;53:470-475.
10. Naluai AT, Nilsson S, Samuelsson L, Gudjonsdottir AH, Ascher H, Ek J, Hallberg B, Kristiansson B, Martinsson T, Nerman O, Sollid LM, Wahlstrom J. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens 2000;56(4):350-355.
11. Martín-Pagola A, Bilbao JR, Ortiz L, Zubillaga P, Castano L. No evidence of association of CTLA4 with celiac disease in the Basque population. J Pediatr Gastroenterol Nutr 2003; 37:142-145.
12. Houlston RS, Tomlinson IP, Ford D, Seal S, Marossy AM, Ferguson A, Holmes GK, Hosie KB, Howdle PD, Jewell DP, Godkin A, Kerr GD, Kumar P, Logan RF, Love AH, Johnston S, Marsh MN, Mitton S, O'Donoghue D, Roberts A, Walker-Smith JA, Stratton MF. Linkage analysis of candidate regions for coeliac disease genes. Hum Mol Genet 1997;6: 1335-1339.
13. King AL, Yiannakou JY, Brett PM, Curtis D, Morris MA, Dearlove AM, Rhodes M, Rosen-Bronson S, Mathew C, Ellis HJ, Ciclitira PJ. A genome-wide family-based linkage study of coeliac disease. Ann Hum Genet 2000;64:479-490.
14. Thomasset M. Vitamin D and the immune system. Pathologie et Biologie 1994;42:163-172.
15. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992;49:26-31.
16. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000;374:334-338.
17. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000;164:4443-4451.
18. Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Investig 1984;74:657-666.
19. Yang S, Smith C, Prahl JM, Luo X, DeLuca HF. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys 1993;303:98-106.
20. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1 alpha, 25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002;51:1367-1374.
21. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Investig 1998;101:252-262.
22. Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Investig 1991;87:1103-1107.
23. Lemire JM, Ince A, Takashima M. 1,25 dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/1 mice. Autoimmunity 1992;12:143-148.
24. Cantorna MT, Hayes CE, DeLuca HF. 1,25 Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998;128:68-72.
25. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of type 1 diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994;37:552-558.
26. Green A, Gale EAM, Patterson CC, EURODIAB ACE study group. Incidence of chilhood onset insulin-dependent diabetes mellitus: The EURODIAB ACE study. Lancet 1992; 339:905-909.
27. The EURODIAB substudy 2 study group. Vitamin D supplement in early childhood and risk for type 1 (insulin-dependet) diabetes mellitus. Diabetologia 1999;42:51-54.
28. Walker-Smith JA, Sandhu BK, Isolauri E, Banchini G, Van Caillie-Bertrand M, Dias JA, Fasano A, Guandalini S, Hoekstra JH, Juntunen M, Kolacek S, Marx D, Micetic-Turk D, Razenberg MC, Szajewska H, Taminiau J, Weizman Z, Zanacca C, Zetterstrom R. Guidelines prepared by the ESPGAN Working Group on Acute Diarrhoea. Recommendations for feeding in childhood gastroenteritis. J Pediatr Gastroenterol Nutr 1997;24:619-620.
29. WHO study group on diabetes mellitus. WHO technical report series 1985; No. 727. WHO Geneva, Switzerland.
30. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, Badenhoop K. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000;49:504-507.
31. Zhao H. Family-based association studies. Stat Methods Med Res 2000;9:563-587.
32. Rohde K, Fuerst R. Haplotyping and estimation of haplotype frequencies for closely linked biallelic multilocus genetic phenotypes including nuclear family information. Hum Mutat 2001;17:289-295.
33. Vogelsang H, Suk EK, Janisiw M, Stain C, Mayr WR, Panzer S. Calcaneal ultrasound attenuation and vitamin-D-receptor genotypes in celiac disease. Scand J Gastroenterol 2000; 35:172-176.
34. Uitterlinden AG, Pols HA, Burger H, Huang Q, Van Daele PL, Van Duijn CM, Hofman A, Birkenhager JC, Van Leeuwen JP. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res 1996;11:1241-1248.
35. Carling T, Ridefelt P, Hellman P, Rastad J, Akerstrom G. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 1997;82:1772-1775.
36. Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves'disease. Thyroid 2000;10:475-480.
37. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid 2001;11:607-608.
38. Hayes CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis. P Soc Exp Biol Med 1997;216:21-27.
39. Chang TJ, Lei HH, Yeh JI, Chiu KC, Lee KC, Chen MC, Thi TY, Chuang LM. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol 2000;52:575-580.
40. McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, Snehalatha C, Hitman GA. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997;40:971-975.
41. Guja C, Marshall S, Welsh K, Merriman M, Smith A, Todd JA, Ionescu-Tirgoviste C. The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population. J Cell Mol Med 2002;6:75-81.
42. Skrabic V, Zemunik T, Situm M, Terzic J. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in the Dalmatian population. Diabetes Res Clin Pract 2003; 59:31-35.
43. Turpeinen H, Hermann R, Vaara S, Laine AP, Simell O, Knip M, Veijola R, Ilonen J. Vitamin D receptor polymorphisms: No association with type 1 diabetes in the Finnish population. Eur J Endocrinol 2003;149:591-596.
44. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000;14:401-420.
45. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher MI, Encinas Dominguez C, Haussler MR. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001;177:145-159.